Deadly partnership to bolster First Nations representation in medical research
Posted: 27 May 2022 WEHI has partnered with leading Indigenous not-for-profit, DeadlyScience, to foster the next generation of Aboriginal and Torres Strait Islander scientists, in the first partnership of its kind. At a glance WEHI partners with DeadlyScience to pave the…
Burnet Institute partners with Moderna to develop novel mRNA vaccines
Posted: 26 May 2022 Media Release: 18 May 2022 Burnet Institute is to partner with world-leading mRNA vaccine manufacturer Moderna, through their cutting-edge mRNA Access program, to develop novel mRNA vaccines for a range of emerging and neglected infectious…
Regulation of Cosmetics in Australia
Posted: 24 May 2022 Stephens Lawyers & Consultants Introduction The importation, manufacture, advertising and supply of cosmetics in Australia is highly regulated and complex. Before a cosmetic product or range can be launched in the Australian market –…
AI created Inventions or Works – Are they protected by Australian IP laws?
Posted: 24 May 2022 Katarina Klaric, Principal, Stephens Lawyers & Consultants Artificial intelligence (AI) and automated decision-making technology is being deployed by government and business to automate or improve operational capabilities. AI technology or systems also are increasingly…
VivaZome to collaborate with UQ Traumatic Brain Injury experts to develop exosome-based therapies
Posted: 20 May 2022 19th May 2022; Melbourne, Australia: VivaZome Therapeutics Pty Ltd (VivaZome) today announced that it has entered into a Memorandum of Understanding (MoU) with The University of Queensland (UQ) focussing on improved therapies for Traumatic…
ENA Respiratory Selected for BLUE KNIGHT™ to Accelerate Development of Pan-Antiviral Nasal Spray
Posted: 19 May 2022 Sydney, Australia, 11th May 2022 – ENA Respiratory, a clinical-stage pharmaceutical company developing INNA-051, a first-in-class broad-spectrum antiviral innate immunomodulator for pan-antiviral prophylaxis in at-risk populations and pandemic preparedness, has been selected to join…
$180m redevelopment of St Vincent’s Private Hospital Fitzroy set to begin
Posted: 19 May 2022 Construction set to begin on $180 million St Vincent’s Private Hospital Fitzroy redevelopment St Vincent’s Health Australia will mark the start of construction of its state-of-the-art, $180m Fitzroy private hospital redevelopment with a sod-turning…
Bionics Institute Excellence in Medical Device Innovation Award – nominations close 13 May
Posted: 6 May 2022 Nominations close: 13 May 2022 Nominations for the Bionics Institute 2022 Award for Excellence in Medical Device Innovation close on Friday 13 May. This accolade recognises an Australian who, through innovation, has made a…
Tessara Therapeutics reinforces Advisory Board with the appointment of global industry leaders in 3D tissue models for drug discovery and cell therapies
Posted: 3 May 2022 Tessara Therapeutics, an Australian biotechnology company developing synthetic human brain micro-tissues as drug screening and neuro-regenerative medicine platforms, continues to ready itself for commercial entry with a series of high-profile Advisory Board appointments. Tessara…
Cancer Therapeutics CRC/Canthera Discovery win CRA Award for Research Commercialisation
Posted: 28 April 2022 Canthera Discovery is delighted to announce that its predecessor, Cancer Therapeutics CRC, received the Cooperative Research Australia (CRA) Excellence in Innovation Award for Research Commercialisation at an award ceremony at Parliament House in Canberra…
Presentation at the Lucust Walk Stem Cell Tx Conference
Posted: 8 April 2022 Event Date: 12 April 2022 Dr Ian Nisbet Chief Operating Officer Held in partnership with Harvard Stem Cell Institute, this virtual one-day investor and partner conference will explore stem cell therapeutics in the areas…
Cartherics CEO Alan Trounson ranked among the world’s most prominent scientists
Posted: 4 April 2022 The respected scientific platform Research.com has published the 2022 Edition of its Ranking of Top 1000 Scientists in the area of Biology and Biochemistry. BioMelbourne Network Member Cartherics welcomes the findings. In a notice…
